Skip to main content
AtriCure, Inc. logo

AtriCure, Inc. — Investor Relations & Filings

Ticker · ATRC ISIN · US04963C2098 LEI · 254900B2I6GPHK2EXM59 US Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2012-01-03 Director's Dealing
Country US United States of America
Listing US ATRC

About AtriCure, Inc.

https://www.atricure.com

AtriCure, Inc. is a medical device company focused on developing, manufacturing, and selling technologies for the treatment of atrial fibrillation (Afib), management of the left atrial appendage (LAA), and post-operative pain. The company's product portfolio is primarily utilized by cardiothoracic surgeons and electrophysiologists. Key offerings include surgical ablation systems and the AtriClip® LAA Exclusion System, a widely implanted device for LAA management. Additionally, AtriCure provides cryoablation technology, such as the cryoXT™ Probe, which offers a non-opioid approach to pain management following surgical procedures, including amputation.

Recent filings

Filing Released Lang Actions
4 Filing
Director's Dealing
2012-01-03 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The content includes an announcement of FDA approval of a medical device and a press release attached as an exhibit. There are no financial statements or detailed financial data presented. The document is short (2213 characters) and primarily serves as a regulatory announcement of an event rather than a financial report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2011-12-16 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated November 17, 2011. It announces the closing of enrollment in a clinical trial and includes a press release as an exhibit. The document is short (2144 characters) and primarily serves as an announcement of an event rather than providing detailed financial data or comprehensive reporting. It does not contain financial statements, management discussion, or detailed disclosures typical of annual or quarterly reports. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings that do not fit other specific categories.
2011-11-17 English
10-Q Filing
Interim / Quarterly Report 9M 2011
2011-11-04 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and references a press release about third quarter financial results. It also states that the press release is furnished as an exhibit and is not "filed" for purposes of Section 18, indicating this is an announcement rather than a full earnings report. The document length is short (2807 characters), and it primarily serves to announce the earnings release and conference call, not to provide detailed financial statements or analysis. Therefore, this document is best classified as an Earnings Release (ER) announcement rather than a full Interim/Quarterly Report (IR) or Annual Report (10-K).
2011-11-01 English
4 Filing
Director's Dealing
2011-10-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.